Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass E, Marsh M, Mangione C, Bressler N, et al. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass E, Marsh M, Mangione C, Bressler N, et al
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Vision conditions cause activity limitations in 8.9% of Americans age 85 and older.  
  • Between 40% and 45% of all diabetics have some stage of diabetic retinopathy.  
  • Glaucoma is responsible for 3 out of every 4 cases of visual impairment in the U.S.  
  • Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.  
  • By 2020, the number of Americans age 40 and older with low vision is projected to reach 3.9 million– growing from 2.4 million in 2004.